Investing with Boyan

Over the last couple of weeks I initiated a position in Ondine Biomedical(OBI). Ondine is a s a Canadian life sciences company focused on developing and commercializing light-based, non-antibiotic antimicrobial therapies to prevent and treat infections in hospitals and other settings. Its core platform, called photodisinfection, uses a photosensitive agent activated by light to rapidly … Continue reading New trade. Ondine Biomedical →

Generally good update. The business is doing well in a challenging environment, but the fact that they have production facilities in multiple countries helps a lot with the tariff malarkey. None the less, I sold about 1/3 of my shares on the day, as usually Volex rallies strongly on results and then sells off(I am … Continue reading Volex half year update(12th of Nov) →

Yesterday(20th Nov), Mitie updated the market with its H1 26 results. I thought the results were excellent (organic revenue growth of 6.4%, overall growth of 10.4%), with all levels growing despite increases in costs(NIC) which I suspect over the long term would roll over into pricing as contracts renew. The pipeline seems excellent(bidding pipeline is … Continue reading Mitie H1 26 trading update →

Very disappointing trading update from Hilton Foods. While this has been a long term holding of mine, it is also the one which has gone the most since purchase. This is the second time in a few months that they updated the market negatively. I have a 3 strikes out rule and this is the … Continue reading Hilton Foods →

Over the past several weeks I’ve done a few more trades. I completely sold out of Alumasc prior to the results(which I am extremely pleased about as it come off by about 20% since then). I think the building business is quite tough in the moment(another one of my holdings Billington had to close down … Continue reading New trades →

2 out of the 3 beat expectations and the share price action reflected this. While Meta’s core results were great, the significant CAPEX spending on AI is spooking investors. I would likely use this opportunity to top up if the shares drop any further. While I am not a big fan of Google’s Gemini(Open AI … Continue reading Google, Meta and Amazon results →

There is speculation in the markets today that the UK Chancellor would remove the exemption from the NIC contribution to partnerships and LLPs. This would predominantly affect law and accountancy firms. As a result I have decided to exit my positions in FRP and scale down substantially my Begbies position. On balance the changes should … Continue reading Proposed changes to NIC contribution for partnerships →

Very strong update from Mitie for H126. Upgrading profit guidance by 11% vs 2025 as well as similar upgrade to market consensus. Integration with Marlow is going as planned, so all is looking positive. The only small concern is that the TCV(Total Contract value) is below H1 25 at £3bn. But still much higher than … Continue reading Mitie H1 trading update →